1. Bloomer RJ, Smith WA, Fisher-Wellman KH. Glycine propionyl-L-carnitine increases plasma nitrate/nitrite in resistance trained menJ Int Soc Sports Nutr. (2007)
  2. Pormsila W, Krähenbühl S, Hauser PC. Determination of carnitine in food and food supplements by capillary electrophoresis with contactless conductivity detectionElectrophoresis. (2010)
  3. Kraemer WJ, Volek JS, Dunn-Lewis C. L-carnitine supplementation: influence upon physiological functionCurr Sports Med Rep. (2008)
  4. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolismAnn N Y Acad Sci. (2004)
  5. Lombard KA, et al. Carnitine status of lactoovovegetarians and strict vegetarian adults and childrenAm J Clin Nutr. (1989)
  6. Flanagan JL, et al. Role of carnitine in diseaseNutr Metab (Lond). (2010)
  7. Evans AM, Fornasini G. Pharmacokinetics of L-carnitineClin Pharmacokinet. (2003)
  8. Bach A. Carnitine biosynthesis in mammalsReprod Nutr Dev. (1982)
  9. Bremer J. Carnitine–metabolism and functionsPhysiol Rev. (1983)
  10. Strijbis K, Vaz FM, Distel B. Enzymology of the carnitine biosynthesis pathwayIUBMB Life. (2010)
  11. Rebouche CJ. Ascorbic acid and carnitine biosynthesisAm J Clin Nutr. (1991)
  12. Thoma WJ, Henderson LM. Effect of vitamin C deficiency on hydroxylation of trimethylaminobutyrate to carnitine in the guinea pigBiochim Biophys Acta. (1984)
  13. Utilization of Dietary Precursors for Carnitine Synthesis in Human Adults.
  14. Suskind DL. Nutritional deficiencies during normal growthPediatr Clin North Am. (2009)
  15. Robles-Valdes C, McGarry JD, Foster DW. Maternal-fetal carnitine relationship and neonatal ketosis in the ratJ Biol Chem. (1976)
  16. Cederblad G, Svenningsen N. Plasma carnitine and breast milk carnitine intake in premature infantsJ Pediatr Gastroenterol Nutr. (1986)
  17. Hizel S, et al. Plasma free carnitine levels in 0-12-month-old infants in relation to feeding stylesInt J Vitam Nutr Res. (2006)
  18. Weaver LT, et al. Carnitine deficiency: a possible cause of gastrointestinal dysmotilityActa Paediatr. (1992)
  19. Carnitine status of lactoovovegetarians and strict vegetarian adults and children.
  20. Krajcovicová-Kudlácková M, et al. Correlation of carnitine levels to methionine and lysine intakePhysiol Res. (2000)
  21. Carnitine function and requirements during the life cycle.
  22. Liepinsh E, et al. Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteersJ Pharm Pharmacol. (2011)
  23. Keller U, et al. Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentrationEur J Clin Nutr. (2009)
  24. Ringseis R, et al. Low availability of carnitine precursors as a possible reason for the diminished plasma carnitine concentrations in pregnant womenBMC Pregnancy Childbirth. (2010)
  25. Malaguarnera M.; Pistone G.; Receputo G.; Rapisarda R.; Tomasello F.B.; Motta M.; Maugeri D. Serum Carnitine Levels in CentenariansClinical Drug Investigation. (1999)
  26. Malaguarnera M, et al. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trialAm J Clin Nutr. (2007)
  27. Pistone G, et al. Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigueDrugs Aging. (2003)
  28. Role of Carnitine in Disease.
  29. Cuturic M, et al. Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart reviewJ Psychiatr Pract. (2010)
  30. Răşanu T, et al. Carnitine deficiencyRom J Morphol Embryol. (2012)
  31. Amat di San Filippo C, et al. Cardiomyopathy and carnitine deficiencyMol Genet Metab. (2008)
  32. Systemic Primary Carnitine Deficiency.
  33. Silvério R, et al. l-carnitine and cancer cachexia: Clinical and experimental aspectsJ Cachexia Sarcopenia Muscle. (2011)
  34. Cruciani RA, et al. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled studyJ Pain Symptom Manage. (2009)
  35. Cruciani RA, et al. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysisAnn N Y Acad Sci. (2004)
  36. Gramignano G, et al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapyNutrition. (2006)
  37. Cruciani RA, et al. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II studyJ Pain Symptom Manage. (2006)
  38. Spasov AA, et al. Effects of L-, D-, and DL-carnitine on morphometric parameters of skeletal muscle and exercise performance of laboratory animals receiving carnitine-deficient dietBull Exp Biol Med. (2006)
  39. Gross CJ, Henderson LM, Savaiano DA. Uptake of L-carnitine, D-carnitine and acetyl-L-carnitine by isolated guinea-pig enterocytesBiochim Biophys Acta. (1986)
  40. Rebouche CJ. Effect of dietary carnitine isomers and gamma-butyrobetaine on L-carnitine biosynthesis and metabolism in the ratJ Nutr. (1983)
  41. Rebouche CJ, Engel AG. Carnitine metabolism and deficiency syndromesMayo Clin Proc. (1983)
  42. Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndromePsychosom Med. (2004)
  43. Wiseman LR, Brogden RN. Propionyl-L-carnitineDrugs Aging. (1998)
  44. The Mitochondriotropic Effects of L-carnitine and its Esters in the Central Nervous System.
  45. Mingorance C, et al. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disordersVasc Health Risk Manag. (2011)
  46. Zammit VA. Carnitine acyltransferases: functional significance of subcellular distribution and membrane topologyProg Lipid Res. (1999)
  47. Brevetti G, et al. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over studyEur Heart J. (1992)
  48. Bloomer RJ, Tschume LC, Smith WA. Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human subjectsInt J Vitam Nutr Res. (2009)
  49. Eder K, et al. Free and total carnitine concentrations in pig plasma after oral ingestion of various L-carnitine compoundsInt J Vitam Nutr Res. (2005)
  50. Tein I. Carnitine transport: pathophysiology and metabolism of known molecular defectsJ Inherit Metab Dis. (2003)
  51. Lahjouji K, Mitchell GA, Qureshi IA. Carnitine transport by organic cation transporters and systemic carnitine deficiencyMol Genet Metab. (2001)
  52. Schürch R, et al. The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in ratsEur J Pharmacol. (2010)
  53. Ciacci C, et al. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot studyDig Liver Dis. (2007)
  54. Sahajwalla CG, et al. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteersJ Pharm Sci. (1995)
  55. Mancinelli A, et al. Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liverDrug Metab Dispos. (2000)
  56. Zhang S, et al. Enhanced bioavailability of L-carnitine after painless intradermal delivery vs. oral administration in ratsPharm Res. (2011)
  57. Cao Y, et al. Single dose administration of L-carnitine improves antioxidant activities in healthy subjectsTohoku J Exp Med. (2011)
  58. Kwon OS, Chung YB. HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALCArch Pharm Res. (2004)
  59. Cao Y, et al. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteersClin Invest Med. (2009)
  60. Parnetti L, et al. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer typeEur J Clin Pharmacol. (1992)
  61. Marzo A, et al. Protein binding of L-carnitine family componentsEur J Drug Metab Pharmacokinet. (1991)
  62. Baker H, et al. Absorption and excretion of L-carnitine during single or multiple dosings in humansInt J Vitam Nutr Res. (1993)
  63. Matsumoto Y, et al. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietinBlood Purif. (2001)
  64. Minkler PE, et al. Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometryClin Chem. (2008)
  65. Brass EP. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patientsClin Ther. (1995)
  66. Nałecz KA, et al. Carnitine: transport and physiological functions in the brainMol Aspects Med. (2004)
  67. Insulin stimulates L-carnitine accumulation in human skeletal muscle.
  68. Ebeling P, et al. The association of acetyl-L-carnitine with glucose and lipid metabolism in human muscle in vivo: the effect of hyperinsulinemiaMetabolism. (1997)
  69. Rebouche CJ. Quantitative estimation of absorption and degradation of a carnitine supplement by human adultsMetabolism. (1991)
  70. Rebouche CJ, Lombard KA, Chenard CA. Renal adaptation to dietary carnitine in humansAm J Clin Nutr. (1993)
  71. Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammalsAnnu Rev Nutr. (1998)
  72. Bartlett K, Eaton S. Mitochondrial beta-oxidationEur J Biochem. (2004)
  73. Jogl G, Hsiao YS, Tong L. Structure and function of carnitine acyltransferasesAnn N Y Acad Sci. (2004)
  74. Rosca MG, Lemieux H, Hoppel CL. Mitochondria in the elderly: Is acetylcarnitine a rejuvenatorAdv Drug Deliv Rev. (2009)
  75. Iossa S, et al. Acetyl-L-carnitine supplementation differently influences nutrient partitioning, serum leptin concentration and skeletal muscle mitochondrial respiration in young and old ratsJ Nutr. (2002)
  76. Moriggi M, et al. A DIGE approach for the assessment of rat soleus muscle changes during unloading: effect of acetyl-L-carnitine supplementationProteomics. (2008)
  77. Gadaleta MN, et al. Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitineEur J Biochem. (1990)
  78. Beckman KB, Ames BN. The free radical theory of aging maturesPhysiol Rev. (1998)
  79. Lesnefsky EJ, Hoppel CL. Oxidative phosphorylation and agingAgeing Res Rev. (2006)
  80. Hagen TM, et al. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activityProc Natl Acad Sci U S A. (1998)
  81. Noland RC, et al. Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic controlJ Biol Chem. (2009)
  82. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity.
  83. Paradies G, et al. Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondriaFEBS Lett. (1994)
  84. Moghaddas S, et al. Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondriaJ Gerontol A Biol Sci Med Sci. (2002)
  85. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid.
  86. Liu J, et al. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolitesAnn N Y Acad Sci. (2002)
  87. Musicco C, et al. Rat liver mitochondrial proteome: changes associated with aging and acetyl-L-carnitine treatmentJ Proteomics. (2011)
  88. Chang J, et al. Effect of aging and caloric restriction on the mitochondrial proteomeJ Gerontol A Biol Sci Med Sci. (2007)
  89. Hirai K, et al. Mitochondrial abnormalities in Alzheimer’s diseaseJ Neurosci. (2001)
  90. Dolezal V, Tucek S. Utilization of citrate, acetylcarnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slicesJ Neurochem. (1981)
  91. Smeland OB, et al. Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy miceNeurochem Int. (2012)
  92. Villa RF, Ferrari F, Gorini A. Effect of in vivo L-acetylcarnitine administration on ATP-ases enzyme systems of synaptic plasma membranes from rat cerebral cortexNeurochem Res. (2011)
  93. Ori C, et al. Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake ratsBrain Res. (2002)
  94. Freo U, Dam M, Ori C. Cerebral metabolic effects of acetyl-l-carnitine in rats during agingBrain Res. (2009)
  95. Ando S, et al. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging ratsJ Neurosci Res. (2001)
  96. Behaviour and Degenerative Changes in the Basal Forebrain Systems of Aged Rats (12 Months Old) after Levo-Acetyl-Carnitine Treatments.
  97. Gottfries CG. Pharmacological treatment strategies in Alzheimer type dementiaEur Neuropsychopharmacol. (1990)
  98. Carta A, et al. Acetyl-L-carnitine and Alzheimer’s disease: pharmacological considerations beyond the cholinergic sphereAnn N Y Acad Sci. (1993)
  99. Goo MJ, et al. Protective effects of acetyl-L-carnitine on neurodegenarative changes in chronic cerebral ischemia models and learning-memory impairment in aged ratsArch Pharm Res. (2012)
  100. Sharman EH, et al. Reversal of biochemical and behavioral parameters of brain aging by melatonin and acetyl L-carnitineBrain Res. (2002)
  101. Sano M, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer’s diseaseArch Neurol. (1992)
  102. Rai G, et al. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer’s dementiaCurr Med Res Opin. (1990)
  103. Spagnoli A, et al. Long-term acetyl-L-carnitine treatment in Alzheimer’s diseaseNeurology. (1991)
  104. Passeri M, et al. Acetyl-L-carnitine in the treatment of mildly demented elderly patientsInt J Clin Pharmacol Res. (1990)
  105. Passeri M, et al. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitineInt J Clin Pharmacol Res. (1988)
  106. Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brainInt J Clin Pharmacol Ther Toxicol. (1986)
  107. Hakkou F, Jaouen C, Iraki L. A comparative study of cyproheptadine and DL carnitine on psychomotor performance and memory in healthy volunteersFundam Clin Pharmacol. (1990)
  108. Soczynska JK, et al. Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disordersExpert Opin Investig Drugs. (2008)
  109. Hudson S, Tabet N. Acetyl-L-carnitine for dementiaCochrane Database Syst Rev. (2003)
  110. Van Oudheusden LJ, Scholte HR. Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorderProstaglandins Leukot Essent Fatty Acids. (2002)
  111. Haorah J, et al. Stabilization of superoxide dismutase by acetyl-l-carnitine in human brain endothelium during alcohol exposure: novel protective approachFree Radic Biol Med. (2011)
  112. Rump TJ, et al. Acetyl-L-carnitine protects neuronal function from alcohol-induced oxidative damage in the brainFree Radic Biol Med. (2010)
  113. Dhitavat S, et al. Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levelsNeurochem Res. (2002)
  114. Calabrese V, et al. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2J Neurosci Res. (2005)
  115. Kitamura Y, et al. Effect of L-carnitine on erythroid colony formation in mouse bone marrow cellsNephrol Dial Transplant. (2005)
  116. Matsumura M, et al. Effect of L-carnitine and palmitoyl-L-carnitine on erythroid colony formation in fetal mouse liver cell cultureAm J Nephrol. (1998)
  117. Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients.
  118. Strasser A, et al. L-Carnitine L-tartrate (LCLT) and dehydroepiandrosterone sulfate (DHEAS) affect red and white blood cells in aged Sprague-Dawley ratsArch Gerontol Geriatr. (2007)
  119. Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacologyAm J Kidney Dis. (2003)
  120. Pekala J, et al. L-carnitine–metabolic functions and meaning in humans lifeCurr Drug Metab. (2011)
  121. Eknoyan G, Latos DL, Lindberg J; National Kidney Foundation Carnitine Consensus Conference. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus ConferenceAm J Kidney Dis. (2003)
  122. Effects of L-Carnitine Supplementation in Maintenance Hemodialysis Patients: A Systematic Review.
  123. Bommer J. Saving erythropoietin by administering L-carnitineNephrol Dial Transplant. (1999)
  124. Hurot JM, et al. Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic reviewJ Am Soc Nephrol. (2002)
  125. Chen Y, et al. L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysisAm J Clin Nutr. (2014)
  126. Yeun JY, et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patientsAm J Kidney Dis. (2000)
  127. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
  128. McMackin CJ, et al. Effect of combined treatment with alpha-Lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery diseaseJ Clin Hypertens (Greenwich). (2007)
  129. Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk. Effects of Acetyl-L-Carnitine Therapy.
  130. Ruggenenti P, et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapyHypertension. (2009)
  131. Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudicationJ Am Coll Cardiol. (1999)
  132. Brevetti G, et al. A new therapeutic proposal for intermittent claudication. Propionyl-L-carnitine: new indications concerning mechanism of actionMinerva Cardioangiol. (1998)
  133. Hiatt WR, et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudicationAm J Med. (2001)
  134. Brevetti G, et al. Effect of propionyl-L-carnitine on quality of life in intermittent claudicationAm J Cardiol. (1997)
  135. Doggrell SA. Pharmacotherapy of intermittent claudicationExpert Opin Pharmacother. (2001)
  136. Brevetti G, et al. Microcirculation and tissue metabolism in peripheral arterial diseaseClin Hemorheol Microcirc. (1999)
  137. Barker GA, et al. Effect of propionyl-L-carnitine on exercise performance in peripheral arterial diseaseMed Sci Sports Exerc. (2001)
  138. Hiatt WR, et al. Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery diseaseJ Cardiopulm Rehabil Prev. (2011)
  139. Fannin SW, et al. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondriaArch Biochem Biophys. (1999)
  140. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle.
  141. Lesnefsky EJ, et al. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding siteJ Mol Cell Cardiol. (2001)
  142. Aging defect at the QO site of complex III augments oxyradical production in rat heart interfibrillar mitochondria.
  143. Lesnefsky EJ, et al. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondriaAm J Physiol. (1997)
  144. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysisAm J Physiol. (1983)
  145. Asimakis GK, Conti VR. Myocardial ischemia: correlation of mitochondrial adenine nucleotide and respiratory functionJ Mol Cell Cardiol. (1984)
  146. Mitochondria and Apoptosis.
  147. Lesnefsky EJ, et al. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experienceJ Am Coll Cardiol. (1996)
  148. Lesnefsky EJ, et al. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heartJ Lab Clin Med. (1994)
  149. Reversal of mitochondrial defects before ischemia protects the aged heart.
  150. Gómez LA, Heath SH, Hagen TM. Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the L-carnitine content in the rat heartMech Ageing Dev. (2012)
  151. Kates AM, et al. Impact of aging on substrate metabolism by the human heartJ Am Coll Cardiol. (2003)
  152. McMillin JB, et al. Mitochondrial metabolism and substrate competition in the aging Fischer rat heartCardiovasc Res. (1993)
  153. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts.
  154. L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis.
  155. Rizzon P, et al. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effectsEur Heart J. (1989)
  156. The Effect of L-Carnitine on Left Ventricular Function in Patients with Acute Myocardial Infarction Treated with Streptokinase.
  157. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction.
  158. Tarantini G, et al. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trialCardiology. (2006)
  159. Xue YZ, et al. L-carnitine as an adjunct therapy to percutaneous coronary intervention for non-ST elevation myocardial infarctionCardiovasc Drugs Ther. (2007)
  160. Effect of L-Carnitine on the Limitation of Infarct Size in One-Month Postmyocardial Infarction Cases.
  161. Martina B, et al. Anti-arrhythmia treatment using L-carnitine in acute myocardial infarctSchweiz Med Wochenschr. (1992)
  162. Iliceto S, et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) TrialJ Am Coll Cardiol. (1995)
  163. Iyer R, et al. Does left ventricular function improve with L-carnitine after acute myocardial infarctionJ Postgrad Med. (1999)
  164. De Pasquale B, Righetti G, Menotti A. L-carnitine for the treatment of acute myocardial infarctCardiologia. (1990)
  165. Brandsch C, Eder K. Effect of L-carnitine on weight loss and body composition of rats fed a hypocaloric dietAnn Nutr Metab. (2002)
  166. Melton SA, et al. L-carnitine supplementation does not promote weight loss in ovariectomized rats despite endurance exerciseInt J Vitam Nutr Res. (2005)
  167. Rebouche CJ. Carnitine function and requirements during the life cycleFASEB J. (1992)
  168. Villani RG, et al. L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese womenInt J Sport Nutr Exerc Metab. (2000)
  169. Karanth J, Jeevaratnam K. Effect of carnitine supplementation on mitochondrial enzymes in liver and skeletal muscle of rat after dietary lipid manipulation and physical activityIndian J Exp Biol. (2010)
  170. Broad EM, Maughan RJ, Galloway S DR. Effects of exercise intensity and altered substrate availability on cardiovascular and metabolic responses to exercise after oral carnitine supplementation in athletesInt J Sport Nutr Exerc Metab. (2011)
  171. Broad EM, Maughan RJ, Galloway SD. Carbohydrate, protein, and fat metabolism during exercise after oral carnitine supplementation in humansInt J Sport Nutr Exerc Metab. (2008)
  172. Vukovich MD, Costill DL, Fink WJ. Carnitine supplementation: effect on muscle carnitine and glycogen content during exerciseMed Sci Sports Exerc. (1994)
  173. Gorostiaga EM, Maurer CA, Eclache JP. Decrease in respiratory quotient during exercise following L-carnitine supplementationInt J Sports Med. (1989)
  174. Sachan DS, Hongu N. Increases in VO2max and metabolic markers of fat oxidation by caffeine, carnitine, and choline supplementation in ratsJ Nutr Biochem. (2000)
  175. Chapela SP, et al. Involvement of L-carnitine in cellular metabolism: beyond Acyl-CoA transportMini Rev Med Chem. (2009)
  176. Zhang L, et al. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscleBiochim Biophys Acta. (2010)
  177. L-Carnitine Improves Glucose Disposal in Type 2 Diabetic Patients.
  178. Capaldo B, et al. Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patientsDiabetes Res Clin Pract. (1991)
  179. Molfino A, et al. Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolismJPEN J Parenter Enteral Nutr. (2010)
  180. Galloway SD, Craig TP, Cleland SJ. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese malesAmino Acids. (2011)
  181. Lohninger A, et al. Relationship between carnitine, fatty acids and insulin resistanceGynakol Geburtshilfliche Rundsch. (2009)
  182. Fisher JS, et al. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulinAm J Physiol Endocrinol Metab. (2002)
  183. Zhang Z, et al. Acetyl-l-carnitine inhibits TNF-alpha-induced insulin resistance via AMPK pathway in rat skeletal muscle cellsFEBS Lett. (2009)
  184. Ringseis R, Keller J, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiencyEur J Nutr. (2012)
  185. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle.
  186. Ho JY, et al. l-Carnitine l-tartrate supplementation favorably affects biochemical markers of recovery from physical exertion in middle-aged men and womenMetabolism. (2010)
  187. Smith WA, et al. Effect of glycine propionyl-L-carnitine on aerobic and anaerobic exercise performanceInt J Sport Nutr Exerc Metab. (2008)
  188. Jacobs PL, et al. Glycine propionyl-L-carnitine produces enhanced anaerobic work capacity with reduced lactate accumulation in resistance trained malesJ Int Soc Sports Nutr. (2009)
  189. Jacobs PL, Goldstein ER. Long-term glycine propionyl-l-carnitine supplemention and paradoxical effects on repeated anaerobic sprint performanceJ Int Soc Sports Nutr. (2010)
  190. Volek JS, et al. L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stressAm J Physiol Endocrinol Metab. (2002)
  191. Kraemer WJ, et al. The effects of L-carnitine L-tartrate supplementation on hormonal responses to resistance exercise and recoveryJ Strength Cond Res. (2003)
  192. Spiering BA, et al. Effects of L-carnitine L-tartrate supplementation on muscle oxygenation responses to resistance exerciseJ Strength Cond Res. (2008)
  193. Bloomer RJ, Fisher-Wellman KH, Tucker PS. Effect of oral acetyl L-carnitine arginate on resting and postprandial blood biomarkers in pre-diabeticsNutr Metab (Lond). (2009)
  194. Spiering BA, et al. Responses of criterion variables to different supplemental doses of L-carnitine L-tartrateJ Strength Cond Res. (2007)
  195. Stuessi C, et al. L -Carnitine and the recovery from exhaustive endurance exercise: a randomised, double-blind, placebo-controlled trialEur J Appl Physiol. (2005)
  196. Decombaz J, et al. Effect of L-carnitine on submaximal exercise metabolism after depletion of muscle glycogenMed Sci Sports Exerc. (1993)
  197. Cha YS, et al. Effects of carnitine coingested caffeine on carnitine metabolism and endurance capacity in athletesJ Nutr Sci Vitaminol (Tokyo). (2001)
  198. Colombani P, et al. Effects of L-carnitine supplementation on physical performance and energy metabolism of endurance-trained athletes: a double-blind crossover field studyEur J Appl Physiol Occup Physiol. (1996)
  199. Fatouros IG, et al. Effects of L-carnitine on oxidative stress responses in patients with renal diseaseMed Sci Sports Exerc. (2010)
  200. Tissue Carnitine Accretion and Fat Metabolism in Rats Supplemented with Carnitine, Choline and Caffeine Regardless of Exercise.
  201. Brass EP. Supplemental carnitine and exerciseAm J Clin Nutr. (2000)
  202. Brass EP. Carnitine and sports medicine: use or abuseAnn N Y Acad Sci. (2004)
  203. Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make senseNutrition. (2004)
  204. Kraemer WJ, et al. Androgenic responses to resistance exercise: effects of feeding and L-carnitineMed Sci Sports Exerc. (2006)
  205. Cavallini G, et al. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male agingUrology. (2004)
  206. Bidzinska B, et al. Effect of different chronic intermittent stressors and acetyl-l-carnitine on hypothalamic beta-endorphin and GnRH and on plasma testosterone levels in male ratsNeuroendocrinology. (1993)
  207. Okada T, et al. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndromeBMC Neurol. (2004)
  208. Kuratsune H, et al. Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brainNeuroimage. (2002)
  209. Hagen TM, et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stressProc Natl Acad Sci U S A. (2002)
  210. Malaguarnera M, et al. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigueArch Gerontol Geriatr. (2008)
  211. Malaguarnera M, et al. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled studyAm J Clin Nutr. (2011)
  212. Malaguarnera M, et al. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathyScand J Gastroenterol. (2011)
  213. Malaguarnera M, et al. Acetyl-L-carnitine treatment in minimal hepatic encephalopathyDig Dis Sci. (2008)
  214. Malaguarnera M, et al. Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trialDig Dis Sci. (2006)
  215. Malaguarnera M, et al. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trialMetab Brain Dis. (2011)
  216. Carroll JK, et al. Pharmacologic treatment of cancer-related fatigueOncologist. (2007)
  217. Laviano A, et al. Antimyopathic effects of carnitine and nicotineCurr Opin Clin Nutr Metab Care. (2006)
  218. Mantovani G, et al. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim resultsNutrition. (2008)
  219. Mantovani G, et al. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexiaOncologist. (2010)
  220. Foitzik K, et al. L-carnitine-L-tartrate promotes human hair growth in vitroExp Dermatol. (2007)
  221. Improvement of sperm quality after micronutrient supplementation.
  222. Christensen QH, Cronan JE. Lipoic acid synthesis: a new family of octanoyltransferases generally annotated as lipoate protein ligasesBiochemistry. (2010)
  223. Daily JW 3rd, Sachan DS. Choline supplementation alters carnitine homeostasis in humans and guinea pigsJ Nutr. (1995)
  224. Dodson WL, Sachan DS. Choline supplementation reduces urinary carnitine excretion in humansAm J Clin Nutr. (1996)
  225. Choline supplementation increases tissue concentrations of carnitine and lowers body fat in guinea pigs.
  226. Hongu N, Sachan DS. Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exerciseJ Nutr. (2000)
  227. Carnitine and Choline Supplementation with Exercise Alter Carnitine Profiles, Biochemical Markers of Fat Metabolism and Serum Leptin Concentration in Healthy Women.
  228. Wawrzeńczyk A, Nałecz KA, Nałecz MJ. Synergistic effect of choline and carnitine on acetylcholine synthesis in neuroblastoma NB-2a cellsBiochem Biophys Res Commun. (1994)
  229. Wawrzeńczyk A, Nałecz KA, Nałecz MJ. Effect of externally added carnitine on the synthesis of acetylcholine in rat cerebral cortex cellsNeurochem Int. (1995)
  230. Kim S, et al. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalphaMol Cell Endocrinol. (2004)
  231. Shin ES, et al. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitineEur J Nutr. (2006)
  232. Yang JY, et al. Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat dietJ Med Food. (2006)
  233. Kumar A, et al. Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon studyActa Cardiol. (2007)
  234. Tempesta E, et al. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholismInt J Clin Pharmacol Res. (1990)
  235. Singh SP, Snyder AK, Eman S. Effects of ethanol on hexose uptake by cultured rat brain cellsAlcohol Clin Exp Res. (1990)
  236. Handa RK, et al. Glucose transporters and glucose utilization in rat brain after acute ethanol administrationMetab Brain Dis. (2000)
  237. Leybaert L. Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic couplingJ Cereb Blood Flow Metab. (2005)
  238. Abdul Muneer PM, et al. Inhibitory effects of alcohol on glucose transport across the blood-brain barrier leads to neurodegeneration: preventive role of acetyl-L: -carnitinePsychopharmacology (Berl). (2011)
  239. Niort G, et al. Effect of dehydroepiandrosterone on human erythrocytes redox metabolism: inhibition of glucose-6-phosphate dehydrogenase activity in vivo and in vitroJ Steroid Biochem. (1985)
  240. Hu ML, Ng HP, Shih MK. Hemolytic effects of dehydroepiandrosterone in vitroLife Sci. (1997)
  241. Bertelli A, Conte A, Ronca G. L-propionyl carnitine protects erythrocytes and low density lipoproteins against peroxidationDrugs Exp Clin Res. (1994)
  242. Sweeney JD, Arduini A. L-carnitine and its possible role in red cell and platelet storageTransfus Med Rev. (2004)
  243. Rubin MR, et al. Safety measures of L-carnitine L-tartrate supplementation in healthy menJ Strength Cond Res. (2001)
  244. Geier DA, et al. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disordersMed Sci Monit. (2011)
  245. Sugino T, et al. Effects of Citric Acid and l-Carnitine on Physical FatigueJ Clin Biochem Nutr. (2007)
  246. Malaguarnera M, et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis–a randomized and controlled clinical trialAm J Gastroenterol. (2010)
  247. Rossini M, et al. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patientsClin Exp Rheumatol. (2007)
  248. Lenzi A, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trialFertil Steril. (2003)
  249. Sigman M, et al. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trialFertil Steril. (2006)
  250. Lenzi A, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermiaFertil Steril. (2004)
  251. Moradi M, et al. Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: a comparative studyUrol J. (2010)
  252. Balercia G, et al. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermiaFertil Steril. (2005)
  253. Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie’s disease: a double-blind, placebo controlled, randomized studyJ Urol. (2007)
  254. Bloomer RJ, Smith WA. Oxidative stress in response to aerobic and anaerobic power testing: influence of exercise training and carnitine supplementationRes Sports Med. (2009)
  255. Bloomer RJ, et al. Comparison of pre-workout nitric oxide stimulating dietary supplements on skeletal muscle oxygen saturation, blood nitrate/nitrite, lipid peroxidation, and upper body exercise performance in resistance trained menJ Int Soc Sports Nutr. (2010)
  256. Martinotti G, et al. Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trialAlcohol Alcohol. (2010)
  257. Gianfrilli D, et al. Propionyl-L-carnitine, L-arginine and niacin in sexual medicine: a nutraceutical approach for erectile dysfunctionAndrologia. (2011)
  258. Tomassini V, et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trialJ Neurol Sci. (2004)
  259. Zanardi R, Smeraldi E. A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymiaEur Neuropsychopharmacol. (2006)
  260. Broad EM, Maughan RJ, Galloway SD. Effects of four weeks L-carnitine L-tartrate ingestion on substrate utilization during prolonged exerciseInt J Sport Nutr Exerc Metab. (2005)
  261. Torrioli MG, et al. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boysAm J Med Genet A. (2008)
  262. Barnett C, et al. Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sprint cyclingInt J Sport Nutr. (1994)
  263. Volek JS, et al. Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adultsAm J Cardiol. (2008)
  264. González-Ortiz M, et al. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patientsAnn Nutr Metab. (2008)
  265. Benvenga S, et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trialJ Clin Endocrinol Metab. (2001)
  266. Martinotti G, et al. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjectsProg Neuropsychopharmacol Biol Psychiatry. (2011)
  267. Wall BT, et al. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humansJ Physiol. (2011)
  268. Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementationClin Sci (Lond). (1992)
  269. Diet and Refsum’s disease. The determination of phytanic acid and phytol in certain foods and the application of this knowledge to the choice of suitable convenience foods for patients with Refsum’s disease.
  270. Rawson ES, et al. Creatine supplementation does not improve cognitive function in young adultsPhysiol Behav. (2008)
  271. Benton D, Donohoe R. The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivoresBr J Nutr. (2011)
  272. Phytanic acid: measurement of plasma concentrations by gas–liquid chromatography–mass spectrometry analysis and associations with diet and other plasma fatty acids.